IVIVC

In Vitro-In Vivo Correlation (IVIVC) is a predictive mathematical model describing the relationship between an in vitro property of a dosage form (usually the rate of drug dissolution) and a relevant in vivo response, e.g., the plasma drug concentration or amount of drug absorbed. The primary purpose of IVIVC is to serve as a surrogate for human bioavailability studies, which can be costly and time-consuming. By establishing a reliable IVIVC, pharmaceutical developers can reduce the need for extensive in vivo studies by predicting the in vivo drug performance based on in vitro data.

Overview

The concept of IVIVC is rooted in the understanding that the physicochemical properties of a drug and its formulation play a crucial role in its dissolution, absorption, and, ultimately, its bioavailability. IVIVC is categorized into different levels (A, B, C, and multiple level C), with Level A being the most informative, establishing a point-to-point relationship between in vitro dissolution and in vivo absorption.

Development and Application

The development of an IVIVC model involves several steps, including the selection of an appropriate in vitro dissolution test, the conduct of in vivo pharmacokinetic studies, and the statistical analysis to establish the correlation. Once established, IVIVC can be used to support regulatory decisions, guide formulation development, and justify biowaivers for minor formulation changes.

Regulatory Perspective

Regulatory agencies, including the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have recognized the importance of IVIVC in the drug development and approval process. Guidelines have been issued to assist in the development and validation of IVIVC models, emphasizing their role in ensuring drug quality and performance.

Challenges and Limitations

Despite its advantages, the development of a robust IVIVC model is not without challenges. Factors such as the complexity of the drug's absorption mechanism, the variability of human physiology, and the limitations of in vitro dissolution testing can impact the accuracy and applicability of IVIVC. Therefore, a thorough understanding of both the drug and its formulation is essential for successful IVIVC development.

Conclusion

IVIVC is a powerful tool in the pharmaceutical development process, offering a scientific basis for predicting in vivo drug performance from in vitro data. When properly developed and validated, IVIVC can significantly streamline drug development and regulatory approval processes, ultimately benefiting both the pharmaceutical industry and patients.

‎